Drug Profile
Formycin A
Latest Information Update: 17 Jul 2001
Price :
$50
*
At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Antibacterials; Antihyperglycaemics; Antineoplastics; Pyrimidines
- Mechanism of Action Gastric inhibitory polypeptide stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus